Who wants to be a millionaire? 3 ASX shares I think could make it happen

The allure of seven figures drives many investors. Here's an example of a way to grow your nest egg to that magic number.

| More on:
a couple clink champagne glasses on board a private aircraft with gourmet food plates set in front of them. They are wearing designer clothes and looking wealthy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Fancy having a million dollars to your name?

Even though there is only a $5 difference between having $999,995 and having a seven-figure amount in your bank account, there is something about the title of "a millionaire" that continues to fascinate investors.

Well with the power of compounding and, of course, ASX shares, you can give the dream a red hot go.

Let's take a look at three stocks that you might consider for your portfolio:

Investing in mining without investing in mining

RPMGlobal Holdings Ltd (ASX: RUL) provides software and technology services to clients in the mining sector.

So it's a way to expose your portfolio to commodities without directly investing in a notoriously cyclical industry.

Created with Highcharts 11.4.3Johns Lyng Group PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Analysts at Forager expressed their bullishness with RPMGlobal recently, saying the recent annual results showed cash flow and profit numbers are rapidly improving.

"Software revenue rose more than 50%, with 56% of that dropping through to the segment profit line," they wrote in a memo to clients.

"This is despite the company paying a management incentive during the year for software sales that will be mostly recognised as revenue in subsequent years."

While past performance is never an indicator of what will happen in the future, RPMGlobal shares have pleased its investors over the past five years, gaining 115% in value.

The business that's growing because of climate change

Insurance construction services provider Johns Lyng Group Ltd (ASX: JLG) has many fans among professional investors.

According to CMC Markets, eight out of 10 analysts currently rate the stock as a buy.

And that popularity continues even after the Johns Lyng share price has rocketed a phenomenal 626% over the past half-decade.

Created with Highcharts 11.4.3Johns Lyng Group PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The Motley Fool's Tristan Harrison is bullish on the stock because of the changing weather patterns due to global warming.

"There seems to be a disappointing trend that there are more damaging and expensive weather events, which can be a tailwind for the level of the company's work and earnings," he said.

"I like that the business is looking to grow in different areas as well, including its move into strata/body corporate services, as well as 'essential home services', such as smoke alarm, electrical, gas compliance, testing and maintenance services."

Cancer treatments are needed the world over

Telix Pharmaceuticals Ltd (ASX: TLX) has doubled its share price over the past 12 months.

And no wonder, as it's rapidly moving its cancer diagnostic and treatment products from the research phase into trials and commercial release.

This is another company that's popular among those who invest for a living.

All seven analysts that cover Telix, as shown on CMC Markets, currently recommend the stock as a buy.

Created with Highcharts 11.4.3Telix Pharmaceuticals PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The Motley Fool's James Mickleboro reported earlier this month that the Bell Potter team is one of those with a buy rating on the pharmaceutical company.  

"Bell Potter remains positive on the company's outlook and is forecasting second-half revenue of $274 million. This represents a 24% increase on its first-half revenues. 

"Looking further ahead, the broker sees multiple uses for PSMA PET agents beyond the label indications. It expects this to support its longer term growth."

Believe it or not, Telix shares have multiplied 13 times in value over the past five years.

A million bucks, here we come

So when can you call yourself a millionaire?

Looking at the five-year performance of the above trio, the median equates to a phenomenal compound annual growth rate (CAGR) of 48.66%.

Even if underperformance from the rest of the portfolio brought that rate down to 20% a year, seven figures is well within reach.

Assume you start with a $30,000 portfolio then you keep adding $300 each month.

After 17 years, that investment will have grown to $1,046,933.

And the best thing?

You only had to put in $91,200 of your money to get there. The rest of it was the sweet returns from the ASX shares plus compounding.

Motley Fool contributor Tony Yoo has positions in Johns Lyng Group and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Johns Lyng Group, RPMGlobal, and Telix Pharmaceuticals. The Motley Fool Australia has recommended Johns Lyng Group, RPMGlobal, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Happy miner giving ok sign in front of a mine.
Opinions

Which ASX 200 stock offers 'material upside' amid continuing uncertainty over US tariffs?

Blackwattle Investment has identified one ASX 200 large-cap stock that is thriving on the uncertainty.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

2 rising ASX financial shares with 'meaningful upside' still left: fundie

Financials outperformed every other sector in FY25, but there are still buying opportunities left, say these experts.

Read more »

A businessman hugs his computer and smiles.
Opinions

If I could only own one ASX 200 share for the rest of my life, it'd be this one

This is one stock I expect to own forever.

Read more »

Man ponders a receipt as he looks at his laptop.
Technology Shares

Brokers rerate 3 leading ASX 200 tech stocks

Experts reveal their ratings on the ASX 200 tech sector's three biggest companies.

Read more »

Person holding a blue chip.
Opinions

Buy alert! 2 ASX 200 blue-chip shares worth a look now: expert

Dylan Evans from Catapult Wealth has identified two blue-chip shares that he thinks are good buys today.

Read more »

Two happy woman on a couch looking at a tablet.
Opinions

Why I'm excited to see the results of these ASX 200 shares

These stocks could reveal very interesting insights.

Read more »

Young male investor smiling looking at laptop as the share price of ASX ETF CRYP goes higher today
Opinions

Why I just bought this 5.2%-yielding ASX dividend stock and plan to buy even more

This business is one of my favourites for dividends and total returns.

Read more »

A young female investor with brown curly hair and wearing a yellow top and glasses sits at her desk using her calculator to work out how much her ASX dividend shares will pay this year
Opinions

Why I'm still investing in ASX shares during tariff uncertainty

There are a few reasons why I plan to continue investing even during uncertainty.

Read more »